Table 3 Clinico-pathological parameters of patients with operable pancreatic cancer (n=110)
Parameter | Number of pancreatic cancer (%) |
|---|---|
Age at operation (years) | |
<65 | 55 (50) |
⩾65 | 55 (50) |
Gender | |
Male | 51 (46.4) |
Female | 59 (53.6) |
UICC stage | |
IB | 2 (1.8) |
IIA | 14 (12.7) |
IIB | 85 (77.3) |
III | 9 (8.2) |
Chemotherapy | |
No chemotherapy | 22 (20) |
Chemotherapy | 88 (80) |
Resection margin | |
R0 | 89 (80.9) |
R1 | 21 (19.1) |
Neutrophil-lymphocyte ratio | |
<5 | 73 (66.4) |
⩾5 | 37 (33.6) |
Platelet-lymphocyte ratio | |
<150 | 28 (25.5) |
⩾150 | 82 (74.5) |
Modified Glasgow prognostic score | |
0 | 73 (66.7) |
1 | 21 (19) |
2 | 16 (14.3) |
